Streetbeat News

Stock Prices

MIRM

Mirum Pharmaceuticals (NASDAQ:MIRM) is scheduled to release its quarterly earnings report on February 28, 2024. Analysts predict an EPS of $-0.24. The company's past performance shows a mixed reaction to earnings reports, with the stock price fluctuating based on actual EPS versus estimates and guidance provided. Shares are currently trading at $29.06, reflecting a 22.91% increase over the last 52 weeks. Investors are optimistic but will be closely watching the guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:01 pm

KNSA

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is scheduled to release its quarterly earnings report on February 28, 2024. Analysts predict an EPS of $-0.14. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Shares are currently trading at $20.16, up 65.71% over the last 52 weeks. Investors are looking for not just an earnings beat but also positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

BBSI

Barrett Bus Servs (NASDAQ:BBSI) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $1.90. Historical data shows the company has previously beaten EPS estimates, leading to positive stock price movements. Shares are currently trading at $115.83, reflecting a 20% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

FCX

Financial analysts have observed a bullish trend in the options market for Freeport-McMoRan (NYSE:FCX), with 55% of traders showing bullish sentiment. The analysis highlighted 9 unusual trades, with a preference for calls over puts, indicating an expectation for FCX's stock price to reach between $30.0 and $42.0 in the next three months. The company, a major international mining entity, has seen its stock price increase by 1.66%, with a current price of $38.66. The next earnings report is expected in 52 days.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

CVX

Financial analysis of Chevron's (NYSE:CVX) options market reveals a bearish sentiment among traders, with 57% showing bearish tendencies. The analysis predicts a price range of $130.0 to $170.0 for Chevron, based on unusual trade activity and options volume and interest. Noteworthy options activity includes both bearish and bullish trades with expiration dates ranging from April 2024 to July 2024. Chevron, a major integrated energy company, has seen its stock price decrease by -0.6%, with a current price of $153.53. Industry analysts have set an average target price of $175.0, with opinions varying from Outperform to Hold.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

EBAY

EL

ULTA

ZM

The CNBC Halftime Report featured final trade recommendations, highlighting Zoom Video Communications (ZM), eBay (EBAY), Estee Lauder (EL), and Ulta Beauty (ULTA). These companies were selected based on their current market performance and potential for future growth.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 6:00 pm

MHO

M/I Homes (NYSE:MHO) has significantly outperformed the market with an annualized return of 23.66% over the past 5 years, resulting in an average annual return of 36.24%. A $100 investment in MHO 5 years ago would now be worth $473.43. The company's current market capitalization stands at $3.40 billion.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

GE

Over the past 5 years, General Electric (NYSE:GE) has outperformed the market with an annualized return of 18.81%, turning a $100 investment into $239.31 today. GE's market capitalization stands at $168.53 billion.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 6:00 pm

IPO

Sweden-based private equity group EQT announced its largest-ever fundraising, securing $24 billion for its EQT X fund, exceeding its target and marking one of the largest private equity funds raised. The fund, focusing on healthcare, technology, and industrial tech, has already made several investments. Amid a private equity slump, EQT expects a pick-up in deal activity and IPO markets reopening in Europe and the US. The Renaissance IPO ETF (NYSE:IPO) has seen a nearly 60% increase since the beginning of 2023.

Portfolio Pulse from Neil Dennis

February 27, 2024 | 5:58 pm

SES

SES shares have experienced an increase following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 5:58 pm